2-(3-Formyl-5-methoxy-1H-indol-1-yl)acetamide

Catalog No.: 
ACISXL662
CAS No.: 
876898-31-6
Molecular Formula: 
C12H12N2O3
Molecular Weight: 
232.24
2-(3-Formyl-5-methoxy-1H-indol-1-yl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$95.00InquiryInquiry
1g97%$271.00InquiryInquiry
5g97%$1328.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(3-Formyl-5-methoxy-1H-indol-1-yl)acetamide
IUPAC Name2-(3-formyl-5-methoxy-1H-indol-1-yl)acetamide
Molecular FormulaC12H12N2O3
Molecular Weight232.24
SMILESO=C(N)CN1C=C(C=O)C2=C1C=CC(OC)=C2
InChI KeyJXAMHUGZRQOWNK-UHFFFAOYSA-N
Synonym2-(3-FORMYL-5-METHOXY-INDOL-1-YL)-ACETAMIDE;ASINEX-REAG BAS 12439447;1H-Indole-1-acetamide, 3-formyl-5-methoxy-
CAS No.876898-31-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACISXL662 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPDIT214 route compound structure diagram
    ACPDIT21410601-19-1In Stock
  2. Plus
  3. ACVSTM124 route compound structure diagram
    ACVSTM124598-42-5In Stock
  4. Then
  5. ACISXL662 route product structure diagram
    ACISXL662876898-31-6
Inquiry

2. ACISXL662 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACISXL662 route product structure diagram
    ACISXL662876898-31-6
Inquiry

3. ACISXL662 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACISXL662 route product structure diagram
    ACISXL662876898-31-6
Inquiry

Comments (0)